|
Volumn 466, Issue 7305, 2010, Pages 443-444
|
Obesity: New life for antidiabetic drugs
a
EPFL
(Switzerland)
|
Author keywords
[No Author keywords available]
|
Indexed keywords
ANTIDIABETIC AGENT;
CYCLIN DEPENDENT KINASE 5;
PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR GAMMA;
ROSCOVITINE;
ROSIGLITAZONE;
CANCER;
CARDIOVASCULAR DISEASE;
DIABETES;
DRUG DEVELOPMENT;
GENE EXPRESSION;
METABOLISM;
OBESITY;
PROTEIN;
ADIPOCYTE;
CELL DIFFERENTIATION;
CONFORMATIONAL TRANSITION;
DIABETES MELLITUS;
DRUG EFFICACY;
GLUCOSE TOLERANCE;
HEART FAILURE;
HUMAN;
INSULIN RESISTANCE;
INSULIN SENSITIVITY;
LIPID DIET;
OBESITY;
OSTEOPOROSIS;
PRIORITY JOURNAL;
PROTEIN EXPRESSION;
PROTEIN PHOSPHORYLATION;
PROTEIN PROCESSING;
SHORT SURVEY;
SIDE EFFECT;
WEIGHT GAIN;
ADIPOSE TISSUE;
ANIMALS;
CYCLIN-DEPENDENT KINASE 5;
DIABETES MELLITUS, EXPERIMENTAL;
DIETARY FATS;
HUMANS;
INSULIN;
LIGANDS;
MICE;
OBESITY;
PHOSPHORYLATION;
PPAR GAMMA;
THIAZOLIDINEDIONES;
|
EID: 77954911499
PISSN: 00280836
EISSN: 14764687
Source Type: Journal
DOI: 10.1038/466443a Document Type: Short Survey |
Times cited : (26)
|
References (15)
|